z-logo
open-access-imgOpen Access
Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase.
Author(s) -
Shirly Lahav-Baratz,
Valery Sudakin,
Joan Ruderman,
Avram Hershko
Publication year - 1995
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.92.20.9303
Subject(s) - cyclin b , ubiquitin ligase , mitosis , cyclin b1 , biology , cyclin dependent kinase 1 , cyclin a , mitotic exit , microbiology and biotechnology , cell cycle , cyclin , biochemistry , cyclin a2 , cyclin d , ubiquitin , cell , anaphase , gene
Cyclin B/cdc2 is responsible both for driving cells into mitosis and for activating the ubiquitin-dependent degradation of mitotic cyclins near the end of mitosis, an event required for the completion of mitosis and entry into interphase of the next cell cycle. Previous work with cell-free extracts of rapidly dividing clam embryos has identified two specific components required for the ubiquitination of mitotic cyclins: E2-C, a cyclin-selective ubiquitin carrier protein that is constitutively active during the cell cycle, and E3-C, a cyclin-selective ubiquitin ligase that purifies as part of a approximately 1500-kDa complex, termed the cyclosome, and which is active only near the end of mitosis. Here, we have separated the cyclosome from its ultimate upstream activator, cdc2. The mitotic, active form of the cyclosome can be inactivated by incubation with a partially purified, endogenous okadaic acid-sensitive phosphatase; addition of cdc2 restores activity to the cyclosome after a lag that reproduces that seen previously in intact cells and in crude extracts. These results demonstrate that activity of cyclin-ubiquitin ligase is controlled by reversible phosphorylation of the cyclosome complex.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here